NCT05601440 2026-02-11Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerCanadian Cancer Trials GroupPhase 2 Recruiting484 enrolled
NCT02101385 2023-09-28Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast CancerHoosier Cancer Research NetworkPhase 2 Completed193 enrolled 21 charts